Pharmacological Targeting of REV-ERBa/bPromotes HIV-1 Reactivation in CD4+T-Cells while Limiting Cell-to-Cell Dissemination
Pharmacological Targeting of REV-ERBa/bPromotes HIV-1 Reactivation in CD4+T-Cells while Limiting Cell-to-Cell Dissemination. Overall design: Memory CD4+ T cells from 7 HIV-uninfected donors; 3 conditions: DMSO, SR9011, SR8278.